Core Viewpoint - The strategic partnership between Dingxiangyuan and JACC has successfully bridged the gap between Chinese clinicians and global cardiovascular research, enhancing academic collaboration and knowledge dissemination in the field [1][2][5]. Group 1: Achievements of the Partnership - Over the past year, Dingxiangyuan and JACC have collaborated under the vision of "More Health Better Life," focusing on academic exchanges, conference reporting, and empowering physicians [2]. - The launch of the "JACC x Dingxiangyuan" monthly publication has provided Chinese doctors with access to the latest research findings in an understandable format, serving as a vital resource for frontline medical professionals [2]. - The collaboration has led to significant initiatives such as the "Asia's Top Ten Research" announcement at the 2025 China International Cardiovascular Disease Conference, establishing a benchmark for cardiovascular research in Asia [2]. Group 2: Future Directions - The partnership aims to deepen collaboration in academic exchanges and conference reporting, particularly leveraging AI technology to enhance the integration of academic cooperation [6][8]. - Dingxiangyuan plans to utilize its advantages in AI technology and medical applications to further support JACC's academic outreach and influence in the Chinese market [6]. - The future collaboration will focus on making academic knowledge more accessible and engaging through innovative formats, such as the "Top Journal Scout" program, which transforms complex academic content into competitive challenges [3][6].